Childhood Benign Central Nervous System Neoplasm

subtype

Identifier: CI-CAN-00002205
Entity page: /cancer/childhood-benign-central-nervous-system-neoplasm ↗
Edges: 22

Neighbours: 10 drugs10 trials
Drawn: 20 of 20 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Childhood Benign Central Nervous System Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived10 of 10
→ investigated in trials for	Temozolomidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Childhood Benign Central Nervous System Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants

Childhood Benign Central Nervous System Neoplasm studied in …STUDIED_INderived10 of 12show all (up to 200)
→ studied in	NCT00919750completed Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00052780Phase 1 · completed Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00063973Phase 1 · completed Cilengitide in Treating Children With Refractory Primary Brain Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00100880Phase 1 · completed Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00994500Phase 1 · completed Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00004078Phase 2 · completed Irinotecan in Treating Children With Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped ONTOLOGY_EXACT · 12 trials mapped (0 active)	—	—	Childhood Craniopharyngioma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains